Eleva UCITS Eleva Eurp Sel H1 EUR acc |
Performance History | 30/09/2024 |
Growth of 1,000 (EUR) |
Fund | 2.9 | 28.2 | -10.8 | 17.1 | 13.3 | |
+/-Cat | 4.2 | 5.2 | 2.4 | 2.9 | 3.1 | |
+/-Idx | 5.9 | 2.8 | -1.1 | 1.2 | 1.4 | |
Category: Europe Large-Cap Blend Equity | ||||||
Benchmarks: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 10/10/2024 | EUR 1891.44 | |
Day Change | -0.13% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU1920210579 | |
Fund Size (Mil) 10/10/2024 | EUR 6104.97 | |
Share Class Size (Mil) 10/10/2024 | EUR 132.93 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 23/02/2024 | 0.90% |
Investment Objective: Eleva UCITS Eleva Eurp Sel H1 EUR acc |
The Fund seeks to achieve superior long-term risk adjusted returns and capital growth by investing primarily in European equities and equity related securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Armand d’Albufera 26/01/2015 | ||
Eric Bendahan 26/01/2015 | ||
Inception Date 15/01/2019 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
STOXX Europe 600 NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Eleva UCITS Eleva Eurp Sel H1 EUR acc | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 5.70 |
ASML Holding NV | Technology | 5.20 |
Schneider Electric SE | Industrials | 3.06 |
Novartis AG Registered Shares | Healthcare | 2.82 |
NatWest Group PLC | Financial Services | 2.62 |
Increase Decrease New since last portfolio | ||
Eleva UCITS Eleva Eurp Sel H1 EUR acc |